Literature DB >> 22611936

[Association between genetic polymorphism of metabolizing enzymes and DNA repairing enzymes and the susceptibility of lung cancer in Henan population].

Na Wang1, Yongjun Wu, Xiaolei Zhou, Yiming Wu.   

Abstract

OBJECTIVE: To investigate the association between genetic polymorphism of metabolizing enzymes and DNA repairing enzymes and the susceptibility of pulmonary cancer in Henan population.
METHODS: A case-control study of 209 lung cancer patients and 256 healthy control subjects was conducted in Henan population to investigate the role of CYP1A1-Msp1, CYP1A1-exon7, GSTM1, GSTT1, mEH-exon3, mEH-exon4 and XRCC1 in lung cancer. Genotyping was performed by using PCR based restriction fragment length polymorhphism techniques.
RESULTS: The frequency of GSTM1-null, CYP1A1-exon7 mt/mt, mEH-exon3 mt/mt, XRCC1-194 Trp/Trp, XRCC1-280 His/His genotype in the lung cancer case group was significantly higher than that in control group (P < 0.05). The risk of lung cancer was higher in individuals carrying genotypes of GSTM1 (ORadj = 1.76, 95% CI 1.21-2.56, P = 0.005), CYP1A1-exon7 Ile/val + val/val (ORadj = 1.65, 95% CI 1.16-2.39, P = 0.009), mEH-exon3 wt/mt + mt/mt (ORadj = 1.77, 95% CI 1.18-2.64, P = 0.007), XRCC1-194 Arg/Trp + Trp/Trp (ORadj = 1.55, 95% CI 1.07-2.27, P = 0.016) and XRCC1-280 His/His (ORadj = 2.21, 95% CI 1.05-4.52, P = 0.026) than those carrying genotypes of GSTM1 null, CYP1A1-exon7 Ile/Ile, mEH-exon3 wt/wt, XRCC1-194 Arg/Arg and XRCC1-280 Arg/ Arg + Arg/His; There was no significant difference for CYP1A1-Msp1, GSTT1, mEH-exon4, XRCC1-399 genotype between the two groups (P > 0.05).
CONCLUSION: The genetic polymorphisms of CYP1A1-exon7, GSTM1, mEH-exon3, XRCC1-194 and XRCC1-280 might contribute to the risk of developing lung cancer in Henan population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22611936

Source DB:  PubMed          Journal:  Wei Sheng Yan Jiu        ISSN: 1000-8020


  19 in total

Review 1.  CYP1A1 MspI polymorphism and susceptibility to lung cancer in the Chinese population: an updated meta-analysis and review.

Authors:  Xin Wang; Kai Yue; Li-Ran Hao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis.

Authors:  Wenlong Zhai; Ruo Feng; Haiyu Wang; Yadong Wang
Journal:  Tumour Biol       Date:  2015-04-03

3.  Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Authors:  Yan-Zhong Feng; Yi-Ling Liu; Xiao-Feng He; Wu Wei; Xu-Liang Shen; Dao-Lin Xie
Journal:  Tumour Biol       Date:  2014-07-27

4.  Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population.

Authors:  Haiyan Yang; Ruo Feng; Haiyu Wang; Yadong Wang
Journal:  Tumour Biol       Date:  2015-02-11

5.  Note of clarification of data in the paper entitled no association between XRCC1 gene Arg194Trp polymorphism and risk of lung cancer: evidence based on an updated cumulative meta-analysis.

Authors:  Haiyan Yang; Fuye Shao; Haiyu Wang; Yadong Wang
Journal:  Tumour Biol       Date:  2015-03-14

6.  EPHX1 A139G polymorphism and lung cancer risk: a meta-analysis.

Authors:  Hong Liu; Hai-Yan Li; Hong-Jie Chen; Yong-Jie Huang; Shao Zhang; Jing Wang
Journal:  Tumour Biol       Date:  2012-10-09

Review 7.  Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer.

Authors:  Siwen Wang; Jie Zhu; Ruxin Zhang; Siyang Wang; Zongheng Gu
Journal:  Tumour Biol       Date:  2013-02-03

8.  GSTM1 polymorphism and lung cancer risk among East Asian populations: a meta-analysis.

Authors:  Yan Zhao; Junjie Zeng; Yanxi Zhang; Su Lu; Erjiang Zhao; Ziming Huang; Weiquan Lu
Journal:  Tumour Biol       Date:  2014-04-01

9.  EPHX1 rs2234922 polymorphism and lung cancer susceptibility in Asian populations: a meta-analysis.

Authors:  Xuefang Xu; Hongxia Hua; Bing Fan; Qing Sun; Xuedan Guo; Jiawei Zhang
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

10.  CYP2A6, CYP1A1, and CYP2D6 polymorphisms in lung cancer patients from central south China.

Authors:  Feng-mao Huang; Han-chun Chen; Md Asaduzzaman Khan; Fu-lan Yang; Xin-xing Wan; Ai-hua Xu; Fang-dan Ou-yang; Dian-zheng Zhang
Journal:  Med Oncol       Date:  2013-03-08       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.